-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$33.86-12.69% Downside
Verona Pharma plc Frequently Asked Questions
-
What analysts cover Verona Pharma plc?
Verona Pharma plc has been rated by research analysts at H.C. Wainwright, Canaccord Genuity, Jefferies, Piper Sandler, Wedbush, Truist Financial in the past 90 days.